Control of foxo1 gene expression by co-activator p300

Journal of Biological Chemistry

Volumn 289, Issue 7, 2014, Pages 4326-4333

  Wondisford, Anne R ^a   Xiong, Lishou ^a   Chang, Evan ^a   Meng, Shumei ^a   Meyers, David J ^a   Li, Mingsong ^b   Cole, Philip A ^a   He, Ling ^a  

^a JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b SOUTHERN MEDICAL UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

CREB; FOXO; GLUCONEOGENESIS; HISTONE ACETYLASE; P300;

ANIMALS; BUCLADESINE; CELL LINE, TUMOR; CYCLIC AMP RESPONSE ELEMENT-BINDING PROTEIN; FASTING; FORKHEAD TRANSCRIPTION FACTORS; GENE EXPRESSION REGULATION; LIVER; MICE;

EID: 84894192032     PISSN: 00219258     EISSN: 1083351X     Source Type: Journal    
DOI: 10.1074/jbc.M113.540500     Document Type: Article

References (30)

1. Vannucci, R. C., and Vannucci, S. J. (2001) Hypoglycemic brain injury. Semin. Neonatol. 6, 147-155
2. Desouza, C., Salazar, H., Cheong, B., Murgo, J., and Fonseca, V. (2003) Association of hypoglycemia and cardiac ischemia: a study based on continuous monitoring. Diabetes Care 26, 1485-1489
3. Einarsdóttir, A. B., and Stefánsson, E. (2009) Prevention of diabetic retinopathy. Lancet 373, 1316-1318
4. Bellentani, S., and Marino, M. (2009) Epidemiology and natural history of nonalcoholic fatty liver disease (NAFLD). Ann. Hepatol. 8, S4-S8
5. Krebs, E. G. (1989) Role of the cyclic AMP-dependent protein kinase in signal transduction. JAMA 262, 1815-1818
6. Hannenhalli, S., and Kaestner, K. H. (2009) The evolution of Fox genes and their role in development and disease. Nat. Rev. Genet. 10, 233-240
7. Nakae, J., Kitamura, T., Silver, D. L., and Accili, D. (2001) The forkhead transcription factor Foxo1 (Fkhr) confers insulin sensitivity onto glucose-6-phosphatase expression. J. Clin. Invest. 108, 1359-1367
8. Liu, Y., Dentin, R., Chen, D., Hedrick, S., Ravnskjaer, K., Schenk, S., Milne, J., Meyers, D. J., Cole, P., Yates, J., 3rd, Olefsky, J., Guarente, L., and Montminy, M. (2008) A fasting inducible switch modulates gluconeogenesis via activator/coactivator exchange. Nature 456, 269-273
9. Cheng, Z., and White, M. F. (2011) Targeting Forkhead box O1 from the concept to metabolic diseases: lessons from mouse models. Antioxid. Redox Signal. 14, 649-661
10. Buteau, J., Shlien, A., Foisy, S., and Accili, D. (2007) Metabolic diapause in pancreatic beta-cells expressing a gain-of-function mutant of the forkhead protein Foxo1. J. Biol. Chem. 282, 287-293
11. Higuchi, M., Dusting, G. J., Peshavariya, H., Jiang, F., Hsiao, S. T., Chan, E. C., and Liu, G. S. (2013) Differentiation of human adipose-derived stem cells into fat involves reactive oxygen species and Forkhead box O1-mediated up-regulation of antioxidant enzymes. Stem Cells Dev. 22, 878-888
12. van der Horst, A., and Burgering, B. M. (2007) Stressing the role of FoxO proteins in lifespan and disease. Nat. Rev. Mol. Cell Biol. 8, 440-450
13. Asada, S., Daitoku, H., Matsuzaki, H., Saito, T., Sudo, T., Mukai, H., Iwashita, S., Kako, K., Kishi, T., Kasuya, Y., and Fukamizu, A. (2007) Mitogen-activated protein kinases, ERK and p38, phosphorylate and regulate Foxo1. Cell. Signal. 19, 519-527
14. Daitoku, H., Hatta, M., Matsuzaki, H., Aratani, S., Ohshima, T., Miyagishi, M., Nakajima, T., and Fukamizu, A. (2004) Silent information regulator 2 potentiates Foxo1-mediated transcription through its deacetylase activity. Proc. Natl. Acad. Sci. U.S.A. 101, 10042-10047
15. Fukuoka, M., Daitoku, H., Hatta, M., Matsuzaki, H., Umemura, S., and Fukamizu, A. (2003) Negative regulation of forkhead transcription factor AFX (Foxo4) by CBP-induced acetylation. Int. J. Mol. Med. 12, 503-508
16. van der Horst, A., Tertoolen, L. G., de Vries-Smits, L. M., Frye, R. A., Medema, R. H., and Burgering, B. M. (2004) FOXO4 is acetylated upon peroxide stress and deacetylated by the longevity protein hSir2SIRT1I. J. Biol. Chem. 279, 28873-28879
17. Qiang, L., Banks, A. S., and Accili, D. (2010) Uncoupling of acetylation from phosphorylation regulates FoxO1 function independent of its subcellular localization. J. Biol. Chem. 285, 27396-27401
18. He, L., Sabet, A., Djedjos, S., Miller, R., Sun, X., Hussain, M. A., Radovick, S., and Wondisford, F. E. (2009) Metformin and insulin suppress hepatic gluconeogenesis through phosphorylation of CREB-binding protein. Cell 137, 635-646
19. Koo, S. H., Flechner, L., Qi, L., Zhang, X., Screaton, R. A., Jeffries, S., Hedrick, S., Xu, W., Boussouar, F., Brindle, P., Takemori, H., and Montminy, M. (2005) The CREB coactivator TORC2 is a key regulator of fasting glucose metabolism. Nature 437, 1109-1111
20. He, L., Naik, K., Meng, S., Cao, J., Sidhaye, A. R., Ma, A., Radovick, S., and Wondisford, F. E. (2012) Transcriptional co-activator P300 maintains basal hepatic gluconeogenesis. J. Biol. Chem. 287, 32069-32077
21. Lau, O. D., Kundu, T. K., Soccio, R. E., Ait-Si-Ali, S., Khalil, E. M., Vassilev, A., Wolffe, A. P., Nakatani, Y., Roeder, R. G., and Cole, P. A. (2000) HATs off: selective synthetic inhibitors of the histone acetyltransferases P300 and PCAF. Mol. Cell 5, 589-595
22. Bowers, E. M., Yan, G., Mukherjee, C., Orry, A., Wang, L., Holbert, M. A., Crump, N. T., Hazzalin, C. A., Liszczak, G., Yuan, H., Larocca, C., Saldanha, S. A., Abagyan, R., Sun, Y., Meyers, D. J., Marmorstein, R., Mahadevan, L. C., Alani, R. M., and Cole, P. A. (2010) Virtual ligand screening of the P300/CBP histone acetyltransferase: identification of a selective small molecule inhibitor. Chem. Biol. 17, 471-482
23. He, L., Cao, J., Meng, S., Ma, A., Radovick, S., and Wondisford, F. E. (2013) Activation of basal gluconeogenesis by co-activator P300 maintains hepatic glycogen storage. Mol. Endocrinol. 27, 1322-1332
24. Goodman, R. H., and Smolik, S. (2000) CBP/P300 in cell growth, transformation, and development. Genes Dev. 14, 1553-1577
25. Brent, M. M., Anand, R., and Marmorstein, R. (2008) Structural basis for DNA recognition by FoxO1 and its regulation by posttranslational modification. Structure 16, 1407-1416
26. Tsai, K. L., Sun, Y. J., Huang, C. Y., Yang, J. Y., Hung, M. C., and Hsiao, C. D. (2007) Crystal structure of the human FOXO3a-DBD/DNAcomplex suggests the effects of post-translational modification. Nucleic Acids Res. 35, 6984-6994
27. Brunet, A., Sweeney, L. B., Sturgill, J. F., Chua, K. F., Greer, P. L., Lin, Y., Tran, H., Ross, S. E., Mostoslavsky, R., Cohen, H. Y., Hu, L. S., Cheng, H. L., Jedrychowski, M. P., Gygi, S. P., Sinclair, D. A., Alt, F. W., and Greenberg, M. E. (2004) Stress-dependent regulation of FOXO transcription factors by the SIRT1 deacetylase. Science 303, 2011-2015
28. Motta, M. C., Divecha, N., Lemieux, M., Kamel, C., Chen, D., Gu, W., Bultsma, Y., McBurney, M., and Guarente, L. (2004) Mammalian SIRT1 represses forkhead transcription factors. Cell 116, 551-563
29. Yang, Y., Hou, H., Haller, E. M., Nicosia, S. V., and Bai, W. (2005) Suppression of FOXO1 activity by FHL2 through SIRT1-mediated deacetylation. EMBO J. 24, 1021-1032
30. Matsuzaki, H., Daitoku, H., Hatta, M., Aoyama, H., Yoshimochi, K., and Fukamizu, A. (2005) Acetylation of Foxo1 alters its DNA binding ability and sensitivity to phosphorylation. Proc. Natl. Acad. Sci. U.S.A. 102, 11278-11283